Gastric carcinoids escaping the currently available classification

In response to “Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge”, by Lahner E et al. (Scand J Gastroenterol 2014;49:506–10)

Louis de MestierDepartment of Hepato-Gastroenterology and Digestive Oncology, Robert-Debré University Hospital, Reims, FranceCorrespondence[email protected]

Marie-Danièle DieboldDepartment of Pathology, Robert-Debré University Hospital, Reims, France

Franck DevulderDepartment of Hepato-Gastroenterology, Polyclinique Courlancy, Reims, France

Remi PicotCabinet de Pathologie Hippocrate, Bezannes, France

Guillaume CadiotDepartment of Hepato-Gastroenterology and Digestive Oncology, Robert-Debré University Hospital, Reims, France

References

GDelle Fave, DJKwekkeboom, EVan Cutsem, GRindi, BKos-Kudla, UKnigge, et al. ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms. Neuroendocrinology 2012;95:74–87.
PubMed Web of Science ®Google Scholar
HScherübl, GCadiot, RTJensen, TRösch, UStölzel, GKlöppel. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy 2010;42:664–71.
PubMed Web of Science ®Google Scholar
ELahner, EPilozzi, GEsposito, GGalli, BAnnibale. Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge. Scand J Gastroenterol 2014;49:506–10.
PubMed Web of Science ®Google Scholar
CSJianu, RFossmark, TViset, GQviqstad, OSordal, RMarvik, et al. Gastric carcinoids after long-term use of proton pump inhibitor. Aliment Pharmacol Ther 2012;36:644–9.
PubMed Web of Science ®Google Scholar
CSJianu, OJLange, TViset, GQviqstad, TCMartinsen, RFougner, et al. Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor. Scand J Gastroenterol 2012;47:64–7.
PubMed Web of Science ®Google Scholar
HSong, JZhu, DLu. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions (Review). Cochrane Database Syst Rev 2014;12:CD010623.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Gastric carcinoids escaping the currently available classification

In response to “Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge”, by Lahner E et al. (Scand J Gastroenterol 2014;49:506–10)

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Gastric carcinoids escaping the currently available classification

In response to “Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge”, by Lahner E et al. (Scand J Gastroenterol 2014;49:506–10)

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date